Toxic Process Ontology
260 terms(s) returned
Term Type: Class | Record: 51 to 100 of 260 Records | Page: 2 of 6, First Previous Next Last | Show Records Per Page |
- SLCO1A2 (canonical)[Cholestasis]
- SLCO1B1 (canonical)[Cholestasis]
- SLCO1B3 (canonical)[Cholestasis]
- SLCO2B1 (canonical)[Cholestasis]
- SMARCD3 (mol)
- SMO (mol)
- SMPD1 (canonical)[Niemann Pick Disease Type A -B]
- SMPD1 (canonical)[Niemann Pick Disease Type A]
- SMPD1 (canonical)[Niemann Pick Disease Type B]
- SMPD1 (canonical)[Phospholipidosis]
- SMPD1 (mol)
- SMPDL3A (human)[Phospholipidosis]
- SMPDL3A (mol)
- SNAI1 (human) [hepatocarcinogenesis]
- SNAI1 (mol)
- SORBS1 (mol)
- SPON2 (mol)
- SPON2(human) - immune responsor[Phospholipidosis]
- SPON2(human) - tumor metastasis inhibitor[Phospholipidosis]
- SPON2(human)[Phospholipidosis]
- SPON2(mouse) - obesity inhibitor[Phospholipidosis]
- SPON2(predicted)(human)[Phospholipidosis]
- SPTLC2 (mol)
- SPTLC3 (mol)
- SPTLC3 (mouse) [hepatocarcinogenesis]
- SPTLC3 (predicted)(human) [hepatocarcinogenesis]
- SRC signal transduction pathway
- SREBF1 (mol)
- SREBP activation
- SREBP activation [lipidosis]
- SREBP1 (canonical)[Ground glass appearance]
- SREBP1 - inactive form (canonical)[Ground glass appearance]
- SREBP1 inactivation
- SREBP1 inactivation [Ground glass appearance]
- SREBP1C (canonical)[Lipidosis]
- SRPK2 (mol)
- SRPX2 (mol)
- SRPX2 (predicted)(human) [mitochondrial damage]
- SRSF1 (mol)
- SRSF1 [Hepatocarcinogenesis]
- STARD7 (mol)
- STAT1 (canonical)[Fibrosis]
- STAT3 activation
- STAT3 activation [hepatocarcinogenesis]
- STAT3 activation[Mitochondrial disorder]
- STAT3 signal transduction pathway
- STAT3 signaling (primitive)
- STAT3 signaling (primitive) [hepatocarcinogenesis]
- STAT3(human) [hepatocarcinogenesis]
- STAT3(human)[mitochondrial disorder]